Alpha 2.0
Login Register
» Articles » PMID: 17158548

Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients with Resectable Pancreatic Adenocarcinoma

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2006 Dec 13
PMID 17158548
Citations 4
Authors
Ulrich Halm
Affiliations
Soon will be listed here.
Citing Articles

Circulating tumor cells in pancreatic cancer: The prognostic impact in surgical patients.

Teja M, Ocanto A, Counago F World J Clin Oncol. 2024; 15(8):987-991.

PMID: 39193164 PMC: 11346077. DOI: 10.5306/wjco.v15.i8.987.

Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification.

Ren A, Diamandis E, Kulasingam V Mol Cell Proteomics. 2021; 20:100155.

PMID: 34597790 PMC: 9357438. DOI: 10.1016/j.mcpro.2021.100155.

Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.

Zhang Y, Xu Y, Wang D, Kuang T, Wu W, Xu X Int J Clin Oncol. 2020; 26(1):135-144.

PMID: 32959232 DOI: 10.1007/s10147-020-01782-y.

Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy.

Ma N, Wang Z, Zhao J, Long J, Xu J, Ren Z Med Sci Monit. 2017; 23:2315-2323.

PMID: 28512284 PMC: 5443358. DOI: 10.12659/msm.904393.